Tobias Kind, Leader in Computational Metabolomics, Joins Enveda Biosciences – Business Wire

Enveda Biosciences today announced that Tobias Kind, one of the world’s most respected computational metabolomics researchers, is joining the company’s industry-leading data science team as Research Fellow. (Photo: Business Wire)

BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences, a pioneer in small molecule drug discovery using machine learning and metabolomics to harness the potential of natural products, today announced that Tobias Kind, Ph.D., will join the company’s industry-leading data science team as Research Fellow. Dr. Kind is one of the world’s most respected and highly cited researchers in computational metabolomics and natural products research. He will play a key role in driving continued data science innovation for Enveda’s drug discovery platform and the company’s leadership in metabolomics.

Dr. Kind brings more than 25 years of experience to Enveda through his transforming work in the use of mass spectrometry (MS) for the structural elucidation of small molecules…

Read Full Story: https://www.businesswire.com/news/home/20220720005814/en/Tobias-Kind-Leader-in-Computational-Metabolomics-Joins-Enveda-Biosciences

The post Tobias Kind, Leader in Computational Metabolomics, Joins Enveda Biosciences – Business Wire first appeared on SEO, Marketing and Social News | OneSEOCompany.com.

source: https://news.oneseocompany.com/2022/07/20/tobias-kind-leader-in-computational-metabolomics-joins-enveda-biosciences-business-wire_2022072023993.html

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.